Biopharm

RemeGen focuses in scientific research, manufacturing and commercialization to change the way cancer, autoimmune and eye diseases are treated.

Arcutis Biotherapeutics is a privately held clinical-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology.

Soleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver diseases and cancers.

Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on providing systemic administration of therapeutics to patients using our proprietary Adhesive Dermally-Applied Microneedle, or ADAM technology.

We are a biopharmaceutical company providing transformative therapeutic solutions to patients and their families with rare and high disease burden conditions

ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. Acquired by Shire

Verona Pharma plc is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as COPD, cystic fibrosis and asthma.

Trevena is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by Central Nervous System (CNS) conditions.

Tokai Pharmaceuticals (NASDAQ: TKAI), based in Boston, Massachusetts, is focused on translating innovative science to develop and deliver innovative therapies that provide hope and healing for patients living with cancer.